This is a high-growth, cash-pay, primary care and hormone optimization clinic with an integrated med spa, serving a rapidly expanding patient base through both in-person and a recently implemented telehealth offering.

The business has demonstrated exceptional growth, achieving 161% year-over-year growth in Q1 2026 vs. Q1 2025, driven by a scalable membership-based model and strong demand for hormone optimization, primary care, and aesthetic services.

The clinic operates on a cash-pay and membership / recurring revenue model, with a large and growing membership base that provides predictable monthly income and high patient lifetime value.

Financial statements have been audited through 2025 by Squire & Company PC.

With the recent provider hires (revenue generating), the short-term margin compression is reflected in the Q1 2026 numbers, but the recent hires provide a clear path to additional profit expansion as patient panels mature. Additionally, the new service line being introduced in Q2 2026 will also increase profit expansion as it utilizes existing staff and infrastructure with minimal additional cost.

Key Highlights
• Rapid growth, based on a highly scalable business recipe (our secret sauce)
• 161% YoY growth (Q1 2026 vs. Q1 2025)
• Continued strong momentum entering 2026
• Growth driven by patient acquisition, additional providers, and membership expansion
• Additional service line with low overhead but significant incremental revenue being introduced in Q2 2026
• Large, established cash-pay membership base with predictable recurring, monthly revenue
• Strong retention dynamics
• Seller retiring but willing to negotiate a reasonable transition

The business is turnkey & systematized as the owners have developed SOPs for all roles, have a proven staffing model, and an experienced manager that’s expected to remain.
Owners have built a highly scalable business model and platform to support significant growth beyond the current geography.

This opportunity is best suited for licensed healthcare providers or experienced operators with demonstrated ability to manage clinical staff and healthcare operations.

Pricing Note: Due to the Company’s continued rapid growth, including triple-digit year-over-year expansion, the current asking price reflects performance through Q1 2026. The Company expects to update financials and re-evaluate valuation following the close of Q2 2026. Buyers seeking to secure the current valuation should be prepared to enter into a signed Letter of Intent (LOI) or Memorandum of Understanding (MOU) prior to that time.

Our Vetting Process:
1. Once you've expressed interest, we will request additional information from you including the following:
A. Background and relevant experience (clinical, healthcare, or business ownership experience)
B. Access to clinical providers (if not a licensed provider)
C. Estimated purchase capacity and source of funds
D. Timeline for acquisition
E. An executed NDA
2. We will then schedule a short call with you to ask questions and get to know you better.
3. If approved, we will release the full CIM